Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.
about
Surmounting chemoresistance by targeting the Y-box binding protein-1Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data.shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.CD28 family and chronic rejection: "to belatacept...And beyond!".YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage.
P2860
Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@ast
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@en
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@nl
type
label
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@ast
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@en
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@nl
prefLabel
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@ast
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@en
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@nl
P2093
P356
P1476
Discovery of YB-1 as a new imm ...... of regulatory T cell blockade.
@en
P2093
Rimas J Orentas
Weiqing Jing
P304
P356
10.1093/ABBS/GMP092
P577
2009-12-01T00:00:00Z